Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Escobar

Showing results (91-100 of 580) with videos related to

Pageof 58
Sort By:
Semergen|November 15, 2021
[Impact of dapagliflozin on cardiovascular risk factors. Beyond glycemic control]V Pallarés, C Escobar, I Egocheaga, et al.
Semergen|June 30, 2014
[Multifactorial intervention to improve therapeutic compliance and secondary prevention measures after acute coronary syndrome]J A Divisón, C Escobar Cervantes, M Seguí Díaz
Semergen|November 17, 2021
[Dapagliflozin in the prevention and treatment of heart failure]I Egocheaga, C Escobar, V Pallarés, et al.
Pigment Cell Research|October 1, 1995
Melanocytes in the stria vascularis and vestibular labyrinth of the Mongolian gerbil (Meriones unguiculatus)C Escobar, A Zuasti, C Ferrer, et al.
Boletin De Estudios Medicos Y Biologicos|January 1, 1994
Protein malnutrition on suprachiasmatic nucleus cells in rats of three agesL Cintra, A Galván, S Díaz-Cintra, et al.
Semergen|November 22, 2021
[Practical approach of dapagliflozin for the treatment of heart failure. Role of primary care physician]J C Obaya, C Escobar, V Pallarés, et al.
Polymers|July 2, 2021
Advanced Research and Development of Face Masks and Respirators Pre and Post the Coronavirus Disease 2019 (COVID-19) Pandemic: A Critical ReviewEbuka A Ogbuoji, Amr M Zaky, Isabel C Escobar
Semergen|December 3, 2014
[Does the use of statins modify calorie intake and fat consumption?]M Seguí Díaz, J A Divisón, C Escobar Cervantes
Revista Clinica Espanola|October 27, 2009
[Has improved the application of the European Society of Hypertension Guidelines 2003 by physicians in Spain? Data from the PRETEND study]V Barrios, C Escobar, J A Divison, et al.
Semergen|December 3, 2014
[Bariatric surgery versus intensive treatment in the patient with type 2 diabetes: A follow-up of 3 years]M Seguí Díaz, C Escobar Cervantes, J A Divisón
Pageof 58

Showing results (91-100 of 580) with videos related to

Sort By:
Pageof 58
Semergen|November 15, 2021
[Impact of dapagliflozin on cardiovascular risk factors. Beyond glycemic control]V Pallarés, C Escobar, I Egocheaga, et al.
Semergen|June 30, 2014
[Multifactorial intervention to improve therapeutic compliance and secondary prevention measures after acute coronary syndrome]J A Divisón, C Escobar Cervantes, M Seguí Díaz
Semergen|November 17, 2021
[Dapagliflozin in the prevention and treatment of heart failure]I Egocheaga, C Escobar, V Pallarés, et al.
Pigment Cell Research|October 1, 1995
Melanocytes in the stria vascularis and vestibular labyrinth of the Mongolian gerbil (Meriones unguiculatus)C Escobar, A Zuasti, C Ferrer, et al.
Boletin De Estudios Medicos Y Biologicos|January 1, 1994
Protein malnutrition on suprachiasmatic nucleus cells in rats of three agesL Cintra, A Galván, S Díaz-Cintra, et al.
Semergen|November 22, 2021
[Practical approach of dapagliflozin for the treatment of heart failure. Role of primary care physician]J C Obaya, C Escobar, V Pallarés, et al.
Polymers|July 2, 2021
Advanced Research and Development of Face Masks and Respirators Pre and Post the Coronavirus Disease 2019 (COVID-19) Pandemic: A Critical ReviewEbuka A Ogbuoji, Amr M Zaky, Isabel C Escobar
Semergen|December 3, 2014
[Does the use of statins modify calorie intake and fat consumption?]M Seguí Díaz, J A Divisón, C Escobar Cervantes
Revista Clinica Espanola|October 27, 2009
[Has improved the application of the European Society of Hypertension Guidelines 2003 by physicians in Spain? Data from the PRETEND study]V Barrios, C Escobar, J A Divison, et al.
Semergen|December 3, 2014
[Bariatric surgery versus intensive treatment in the patient with type 2 diabetes: A follow-up of 3 years]M Seguí Díaz, C Escobar Cervantes, J A Divisón
Pageof 58